Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin-related protein T1 is a testis-enriched cytoskeletal protein involved in organizing the junction between the sperm head and flagellum, essential for sperm integrity and motility. It is expressed mainly in the pericentriolar material (PCM) of spermatozoa and regulates Hedgehog pathway signaling by negative modulation. Genetic defects in ACTRT1—including point mutations and insertions—cause acephalic spermatozoa syndrome, which manifests as male infertility due to sperm head-tail separation. Mutations have also been linked with Bazex-Dupré-Christol syndrome, a rare hereditary disorder affecting hair, skin, and potentially other structures. ACTRT1 has a single-exon transcript encoding a 376-amino acid protein. Functional studies in knockout mice confirm its role in sperm cell formation, with knockouts causing headless sperm phenotypes and altered testicular proteome. There is no current evidence to suggest ACTRT1 is a receptor, enzyme, transporter, or transcription factor, nor is it a direct drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-related protein T1 (ACTRT1).